Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sufentanil effects on hemorrhage tolerance
NCT04959812Phase 2Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Mar 2022
- Primary completion
- Sep 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of sufentanil in acute pain, sponsored by UT Southwestern Medical Center. Started Mar 2022; status: completed.
02
Drugs
sufentanil
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT04959812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04959812.